Group One Trading
NMRA icon

Group One Trading’s Neumora Therapeutics NMRA Stock Holding History

Group One Trading’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-44,471
Closed -$61.6K – 8087
2026
Q2 		$75.6K Sell
44,471
-1,571
-3% -$2.99K ﹤0.01% 5082
2026
Q1 		$89.8K Buy
+46,042
New +$119K ﹤0.01% 4831
2024
Q4 		– Sell
-15,776
Closed -$189K – 7731
2024
Q3 		$208K Buy
+15,776
New +$184K ﹤0.01% 3579

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Wellcome Trust
Wellcome Trust London, United Kingdom $9.16B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lunate Capital
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $714M AUM 64.22% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Group One Trading's NMRA Position: Q3 2026 in Review

Group One Trading sold out of Neumora Therapeutics (NMRA) in Q3 2026, closing a stake of 44,471 shares — an estimated $61.6K sold.

Group One Trading first reported a position in NMRA in Q3 2024 and held it in 3 quarters. The position peaked at $208K in Q3 2024. 64 funds tracked by Wall St. Rank hold NMRA as of Q3 2026.

  • Group One Trading reported no remaining Neumora Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Group One Trading sold 44,471 Neumora Therapeutics shares in Q3 2026, an estimated $61.6K.
  • Group One Trading first reported a position in Neumora Therapeutics in Q3 2024 and held it in 3 quarters.
  • Group One Trading's Neumora Therapeutics position peaked at $208K in Q3 2024.
  • 64 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.